Chronic opiate use in pregnancy and newborn head circumference

American Journal of Perinatology

Volumn 32, Issue 1, 2015, Pages 27-31

  Visconti, Kevin C ^a   Hennessy, Kerry C ^a   Towers, Craig V ^a   Howard, Bobby C ^a  

^a UNIVERSITY OF TENNESSEE MEDICAL CENTER   (United States)

Author keywords

neonatal abstinence syndrome; newborn head circumference; opiates; prenatal substance abuse

Indexed keywords

ANATOMY AND HISTOLOGY; CASE CONTROL STUDY; CEPHALOMETRY; FEMALE; GESTATIONAL AGE; HEAD; HUMAN; MALE; NEWBORN; OPIATE ADDICTION; PREGNANCY; PREGNANCY COMPLICATION; PREMATURITY; WITHDRAWAL SYNDROME;

CASE-CONTROL STUDIES; CEPHALOMETRY; FEMALE; GESTATIONAL AGE; HEAD; HUMANS; INFANT, EXTREMELY PREMATURE; INFANT, NEWBORN; INFANT, PREMATURE; MALE; NEONATAL ABSTINENCE SYNDROME; OPIOID-RELATED DISORDERS; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 84899466731     PISSN: 07351631     EISSN: 10988785     Source Type: Journal    
DOI: 10.1055/s-0034-1374817     Document Type: Article

References (23)

1. Patrick S. W., Schumacher R. E., Benneyworth B. D., Krans E. E., McAllister J. M., Davis M. M. Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009. JAMA: 2012; 307 18 1934 1940
2. Joint Commission on Accreditation of Healthcare Organizations Pain Assessment and Management: An Organizational Approach; 2000. Available at http://www.jointcommission.org/assets/1/18/pain-management.pdf
3. Public Law 106-386-Oct. 28, Victims of Trafficking and Violence Protection Act of 2000. Title VI, Section 1603, Decade of pain control and research. 2000
4. National Institute on Drug Abuse Commonly Abused Prescription Drugs. Bethesda, MD NIDA: 2011;. Available at: https://www.drugabuse.gov/sites/default/files/rx-drugs-placemat-508c-10052011.pdf
5. Delsing C., Van Den Wittenboer E., Liu A. JW., et al. The relationship between maternal opiate use, amphetamine use and smoking on fetal growth. Aust N Z J Obstet Gynaecol: 2011; 51 5 446 451
6. Arlettaz R., Kashiwagi M., Das-Kundu S., Fauchère J-C, Lang A., Bucher H-U. Methadone maintenance program in pregnancy in a Swiss perinatal center (II): neonatal outcome and social resources. Acta Obstet Gynecol Scand: 2005; 84 2 145 150
7. Hagopian G. S., Wolfe H. M., Sokol R. J., Ager J. W., Wardell J. N., Cepeda E. E. Neonatal outcome following methadone exposure in utero. J Matern Fetal Med: 1996; 5 6 348 354
8. Lam S. K., To W. K., Duthie S. J., Ma H. K. Narcotic addiction in pregnancy with adverse maternal and perinatal outcome. Aust N Z J Obstet Gynaecol: 1992; 32 3 216 221
9. Little B. B., Snell L. M., Klein V. R., Gilstrap L. C. III, Knoll K. A., Breckenridge J. D. Maternal and fetal effects of heroin addiction during pregnancy. J Reprod Med: 1990; 35 2 159 162
10. Das A., Poole W. K., Bada H. S. A repeated measures approach for simultaneous modeling of multiple neurobehavioral outcomes in newborns exposed to cocaine in utero. Am J Epidemiol: 2004; 159 9 891 899
11. Bada H. S., Bauer C. R., Shankaran S., et al. Central and autonomic system signs with in utero drug exposure. Arch Dis Child Fetal Neonatal Ed: 2002; 87 2 F106 F112
12. Tennessee Department of Health Maternal and Child Health/Neonatal Abstinence Syndrome. Available at: http://health.tn.gov/MCH/NAS; Accessed March 2013
13. Olsen I. E., Groveman S. A., Lawson M. L., Clark R. H., Zemel B. S. New intrauterine growth curves based on United States data. Pediatrics: 2010; 125 2 e214 e224
14. Hadlock F. P., Harrist R. B., Sharman R. S., Deter R. L., Park S. K. Estimation of fetal weight with the use of head, body, and femur measurements-a prospective study. Am J Obstet Gynecol: 1985; 151 3 333 337
15. Nardozza L. M., Araujo Júnior E., Barbosa M. M., Caetano A. C., Lee D. J., Moron A. F. Fetal growth restriction: current knowledge to the general Obs/Gyn. Arch Gynecol Obstet: 2012; 286 1 1 13
16. Restriction F. G.; American College of Obstetricians and Gynecologists. ACOG Practice bulletin no. 134: fetal growth restriction. Obstet Gynecol: 2013; 121 5 1122 1133
17. Jones K. L. The effects of alcohol on fetal development. Birth Defects Res C Embryo Today: 2011; 93 1 3 11
18. Rementeriá J. L., Nunag N. N. Narcotic withdrawal in pregnancy: stillbirth incidence with a case report. Am J Obstet Gynecol: 1973; 116 8 1152 1156
19. Zuspan F. P., Gumpel J. A., Mejia-Zelaya A., Madden J., Davis R. Fetal stress from methadone withdrawal. Am J Obstet Gynecol: 1975; 122 1 43 46
20. Dashe J. S., Jackson G. L., Olscher D. A., Zane E. H., Wendel G. D. Jr. Opioid detoxification in pregnancy. Obstet Gynecol: 1998; 92 5 854 858
21. Luty J., Nikolaou V., Bearn J. Is opiate detoxification unsafe in pregnancy? J Subst Abuse Treat: 2003; 24 4 363 367
22. Stewart R. D., Nelson D. B., Adhikari E. H., et al. The obstetrical and neonatal impact of maternal opioid detoxification in pregnancy. Am J Obstet Gynecol: 2013; 209 3 e1 e5
23. Minnes S., Lang A., Singer L. Prenatal tobacco, marijuana, stimulant, and opiate exposure: outcomes and practice implications. Addict Sci Clin Pract: 2011; 6 1 57 70